Markin S S, Nalivaiko E S, Khalilov E M, Moreino M S, Fedin A I, Teterina E B
Scientific-Research Institute of Physico-Chemical Medicine, Ministry of Public Health of the Russian Federation, Moscow.
Biomater Artif Cells Artif Organs. 1987;15(1):125-35. doi: 10.3109/10731198709118513.
The inclusion of hemosorption through activated coals into the comprehensive treatment of 580 patients sick with atherosclerosis has made it possible to achieve a positive clinical effect among 81 per cent of the patients sick with the ischemic heart disease, 79 per cent of atherosclerotic discirculatory encephalopathy and 76 per cent of obliterating atherosclerosis of lower limbs. The positive dynamics is especially visible among patients who are administered the programmatic hemosorption, making it possible over a long period of time (3-5 years) to sustain remission in the clinical state and the normal level of the lipids in the blood. The direct effect is expressed in the improved microcirculation, disappearance of the sludge-syndrome and the reduction of ischemic disorders. The remote effect of hemosorption is connected with the repeated removals of cholesterin of the atherogenic lipoproteids, which leads, we believe, to the interruption or even regression of the atherosclerotic process.
将通过活性炭进行血液吸附纳入580例动脉粥样硬化患者的综合治疗中，已使81%的缺血性心脏病患者、79%的动脉粥样硬化性血液循环障碍性脑病患者和76%的下肢闭塞性动脉粥样硬化患者取得了积极的临床效果。积极的动态变化在接受计划性血液吸附的患者中尤为明显，这使得在很长一段时间（3至5年）内维持临床状态缓解和血液中脂质的正常水平成为可能。直接效果表现为微循环改善、血液淤滞综合征消失和缺血性疾病减少。血液吸附的远期效果与反复清除致动脉粥样硬化脂蛋白中的胆固醇有关，我们认为这会导致动脉粥样硬化进程的中断甚至逆转。
